The European geriatric medicine market is projected to grow at a CAGR of 5.4% during the forecast period. Geriatric medicine is fostering in Europe with the rising burden of healthcare disorders in elderly people. European Union Geriatric Medicine Society (EUgMS) is a journal that specifically focuses on geriatric medicine in Europe. Its scope includes a comprehensive analysis of all factors of geriatric medicine in the region, both with a clinical and academic focus. This involves setting up the functionality in old age, comprehensive geriatric assessment, geriatric syndromes, education, models of care in health services.
A full report of European Geriatric Medicine Market is available at: https://www.omrglobal.com/industry-reports/europe-geriatric-medicine-market
European Academy for Medicine of Aging (EAMA) is an academic institute that focuses on improving the knowledge and skills in geriatric medicine among the upcoming healthcare providers and specialists. This further includes the discussion regarding the development of new ideas and programs for geriatric health and harmonize practices. Such a huge focus of the European economies towards the development of better healthcare infrastructure for the elderly population will drive the geriatric medicine market growth in the region during the forecast period.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/europe-geriatric-medicine-market
Market Coverage
- Study Period- 2019-2026
- Base year- 2019
- Forecast period- 2020-2026
- Segments Covered- By Therapeutics and By Condition
- Countries Covered- UK, Germany, France, Italy, Spain, and Rest of Europe
- Key Companies Profiled- Novartis AG, GlaxoSmithKline Plc, Sanofi SA, Boehringer Ingelheim GmbH, AstraZeneca PLC, and Pfizer Inc.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in the base year?
- Which segment/region will project the fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
European Geriatric Medicine Market – Segmentation
By Therapeutics
- Analgesic
- Anticoagulant
- Antihypertensive
- Antidiabetic
- Others (Statins and Antipsychotic)
By Condition
- Cardiovascular Diseases (CVDs)
- Diabetes
- Neurological
- Cancer
- Respiratory
- Others (Arthritis and Osteoporosis)
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
